You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 8, 2024

CLINICAL TRIALS PROFILE FOR ROFLUMILAST

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ROFLUMILAST

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00062582 ↗	Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)	Completed	AstraZeneca	Phase 3	2003-06-01	The aim of the study is to compare the effect of roflumilast and placebo on the lung function in patients with COPD.
NCT00073177 ↗	Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)	Completed	AstraZeneca	Phase 3	2003-11-01	The aim of the study is to compare the effects of oral roflumilast with placebo on lung function in patients with asthma.
NCT00076076 ↗	The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)	Completed	AstraZeneca	Phase 3	2003-12-01	The purpose of this study is to confirm the dose of roflumilast to be used for asthma management by comparing the effects of 250 mcg and 500 mcg oral roflumilast with placebo on pulmonary function and asthma symptoms.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ROFLUMILAST

Condition Name

Chart
Table

Condition Name for ROFLUMILAST
Intervention	Trials
Chronic Obstructive Pulmonary Disease	15
COPD	13
Chronic Obstructive Pulmonary Disease (COPD)	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ROFLUMILAST
Intervention	Trials
Pulmonary Disease, Chronic Obstructive	34
Lung Diseases	32
Lung Diseases, Obstructive	30
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ROFLUMILAST

Trials by Country

Map
Table

Trials by Country for ROFLUMILAST
Location	Trials
United States	434
Canada	51
Germany	12
Spain	12
United Kingdom	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ROFLUMILAST
Location	Trials
California	21
Texas	19
Florida	19
Kentucky	16
Pennsylvania	15
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ROFLUMILAST

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ROFLUMILAST
Clinical Trial Phase	Trials
Phase 4	14
Phase 3	36
Phase 2/Phase 3	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ROFLUMILAST
Clinical Trial Phase	Trials
Completed	56
Recruiting	16
Not yet recruiting	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ROFLUMILAST

Sponsor Name

Chart
Table

Sponsor Name for ROFLUMILAST
Sponsor	Trials
AstraZeneca	37
Takeda	11
Arcutis Biotherapeutics, Inc.	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ROFLUMILAST
Sponsor	Trials
Industry	75
Other	59
NIH	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.